发明名称 |
CARBOXYAMIDO DERIVATIVES |
摘要 |
A carboxyamido derivative represented by formula (I) useful as a medicament for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity: wherein R<1> represents 2-hydroxybenzimidazolyl group which may be substituted and the like; Y represents oxygen atom or sulfur atom; R<2> represents hydrogen atom or an alkyl group; n represents 0, 1 or 2; at least one of X<1>, X<2>, X<3, X?4> and X<5> represent (a) NR<3>R<4>, (b) N+R<5>R<6>R<7>, or (c) a nitrogen-containing heterocyclic group having one or more sp<2> nitrogen atoms which may be substituted, in which R<3> and R<4> independently represent hydrogen atom, an alkyl group and the like, or R<3>, N and R<4> may combine together to form a nitrogen-containing heterocyclic group which may be substituted; R<5>, R<6> and R<7> represent an alkyl group and the like, or R<5>, N and R<6> may combine together to form a nitrogen-containing heterocyclic group which may be substituted; or neighboring X<2> and X<3> or X<3> and X<4> and the like may combine together with the benzene ring to form an isoindoline ring and the like, and the rest of them represent hydrogen atom. |
申请公布号 |
WO0142224(A1) |
申请公布日期 |
2001.06.14 |
申请号 |
WO2000JP08690 |
申请日期 |
2000.12.08 |
申请人 |
MITSUBISHI-TOKYO PHARMACEUTICALS, INC.;ANDO, RYOICHI;ARITOMO, KEIICHI;SHODA, AYA;WATANABE, KAZUTOSHI;UEHARA, FUMIAKI;SAITO, KEN-ICHI |
发明人 |
ANDO, RYOICHI;ARITOMO, KEIICHI;SHODA, AYA;WATANABE, KAZUTOSHI;UEHARA, FUMIAKI;SAITO, KEN-ICHI |
分类号 |
A61P7/04;C07D235/02;C07D235/26;C07D401/12;(IPC1-7):C07D235/26;A61K31/418 |
主分类号 |
A61P7/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|